'Life-Changing' MS Drug Could Save NHS £300 Million A Year, UK
Posted Nov 17 2009 10:20pm
Article Date: 22 Oct 2009
The lives of 100,000 Multiple Sclerosis sufferers in the UK could be greatly improved while saving the NHS £300 million a year.
The claim comes from the LDN Research Trust ahead of the first International LDN Awareness Week which begins this monday.
Low DoseNaltrexone, or LDN, is already available on the NHS but not all GPs are prepared to prescribe it to treat MS - Naltrexone has been approved by the Food and Drug Administration (FDA) for treatingalcoholismand drug addiction. LDN uses around 1% of that dose to treat MS.